- Home
- NRGV vs CSBR Comparison
NRGV vs CSBR Comparison
Compare NRGV & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRGV
- CSBR
- Stock Information
- Founded
- NRGV 2017
- CSBR 1985
- Country
- NRGV United States
- CSBR United States
- Employees
- NRGV N/A
- CSBR N/A
- Industry
- NRGV Industrial Machinery/Components
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NRGV Miscellaneous
- CSBR Health Care
- Exchange
- NRGV Nasdaq
- CSBR Nasdaq
- Market Cap
- NRGV 133.4M
- CSBR 123.2M
- IPO Year
- NRGV N/A
- CSBR 1986
- Fundamental
- Price
- NRGV $2.29
- CSBR $6.83
- Analyst Decision
- NRGV Buy
- CSBR Strong Buy
- Analyst Count
- NRGV 3
- CSBR 1
- Target Price
- NRGV $1.58
- CSBR $12.00
- AVG Volume (30 Days)
- NRGV 2.0M
- CSBR 20.7K
- Earning Date
- NRGV 11-11-2025
- CSBR 09-15-2025
- Dividend Yield
- NRGV N/A
- CSBR N/A
- EPS Growth
- NRGV N/A
- CSBR N/A
- EPS
- NRGV N/A
- CSBR 0.33
- Revenue
- NRGV $51,716,000.00
- CSBR $56,944,000.00
- Revenue This Year
- NRGV $314.58
- CSBR $9.30
- Revenue Next Year
- NRGV $39.00
- CSBR $31.17
- P/E Ratio
- NRGV N/A
- CSBR $20.39
- Revenue Growth
- NRGV N/A
- CSBR 13.54
- 52 Week Low
- NRGV $0.60
- CSBR $3.75
- 52 Week High
- NRGV $2.70
- CSBR $11.99
- Technical
- Relative Strength Index (RSI)
- NRGV 70.49
- CSBR 49.84
- Support Level
- NRGV $1.73
- CSBR $6.33
- Resistance Level
- NRGV $2.33
- CSBR $7.25
- Average True Range (ATR)
- NRGV 0.18
- CSBR 0.29
- MACD
- NRGV 0.00
- CSBR -0.02
- Stochastic Oscillator
- NRGV 94.12
- CSBR 51.02
About NRGV Energy Vault Holdings Inc.
Energy Vault Holdings Inc is a grid-scale energy storage company that is driving a faster transition to renewable power by solving the intermittence issues that are inherent to the prevalent sources of renewable energy, solar and wind. Geographical presence in United States, China and Other. Majority of its revenue comes from U.S.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.